科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002422 科伦药业

已收盘 10-27 15:00:00

{"stockData":{"symbol":"002422","market":"SZ","secType":"STK","nameCN":"科伦药业","latestPrice":39.84,"timestamp":1793084586000,"preClose":44.26,"halted":0,"volume":31462969,"delay":0,"changeRate":-0.0999,"floatShares":1299000000,"shares":1591000000,"eps":1.1498,"marketStatus":"已收盘","change":-4.42,"latestTime":"10-27 15:00:00","open":43.82,"high":44.22,"low":39.84,"amount":1296000000,"amplitude":0.099,"askPrice":39.84,"askSize":722,"bidPrice":39.83,"bidSize":2552,"shortable":0,"etf":0,"ttmEps":1.1498,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793151000000},"marketStatusCode":5,"adr":0,"adjPreClose":44.26,"symbolType":"stock","openAndCloseTimeList":[[1793064600000,1793071800000],[1793077200000,1793084400000]],"highLimit":48.69,"lowLimit":39.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1590781208,"isCdr":false,"pbRate":2.86,"roa":"--","peRate":34.649504,"roe":"4.59%","epsLYR":1.07,"committee":0.336826,"marketValue":63377000000,"turnoverRate":0.0242,"status":1,"floatMarketCap":51734000000},"requestUrl":"/m/hq/s/002422","defaultTab":"news","newsList":[{"id":"2678175594","title":"科伦药业：芦康沙妥珠单抗新适应症上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175594","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175594?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:49","pubTimestamp":1793098154,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002422","LU2148510915.USD","LU1064131003.USD","BK0060","BK0239","LU1934453819.USD","LU1979443071.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678596461","title":"科伦药业传利好，子公司抗癌新药两项临床研究登上国际肿瘤大会：或可降低肺癌患者疾病进展风险，效果优于化疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2678596461","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678596461?lang=zh_cn&edition=full","pubTime":"2026-10-26 13:23","pubTimestamp":1792992203,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者穆砚10月26，四川科伦药业股份有限公司（以下简称“科伦药业”或“公司”）发布公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610263907870067.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610263907870067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","LU2148510915.USD","BK0239","002422","BK0060","LU1064131003.USD","LU1934453819.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678156608","title":"科伦药业子公司公布多项创新药物研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2678156608","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678156608?lang=zh_cn&edition=full","pubTime":"2026-10-26 12:31","pubTimestamp":1792989112,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159992","002422","BK1574","LU1934453819.USD","LU1064130708.USD","LU1979443071.USD","BK0239","LU1064131003.USD","BK1161","LU2148510915.USD","BK0060","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678113571","title":"股市必读：10月23日科伦药业现1笔大宗交易 机构净买入6044.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678113571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678113571?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:28","pubTimestamp":1792949291,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，科伦药业报收于42.75元，下跌0.02%，换手率1.66%，成交量21.62万手，成交额9.14亿元。当日关注点交易信息汇总：10月23日科伦药业主力资金净流出2890.89万元，占总成交额3.16%；  交易信息汇总：当日发生1笔大宗交易，机构净买入6044.61万元。大宗交易10月23日科伦药业发生1笔大宗交易，机构净买入6044.61万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1979443071.USD","BK0239","LU1934453819.USD","002422","BK0060","LU1064131003.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940697","title":"10月23日科伦药业现1笔大宗交易 机构净买入6044.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940697?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:39","pubTimestamp":1792748368,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日科伦药业发生大宗交易，交易数据如下：大宗交易成交价格42.75元，成交141.39万股，成交金额6044.61万元，买方营业部为机构专用，卖方营业部为国泰海通证券股份有限公司深圳深南大道京基一百证券营业部。近三个月该股共发生2笔大宗交易，合计成交2.83万手。截至2026年10月23日收盘，科伦药业报收于42.75元，下跌0.02%，换手率1.66%，成交量21.62万手，成交额9.14亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1979443071.USD","BK0239","LU1934453819.USD","002422","BK0060","LU1064131003.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551177","title":"科伦药业（002422）10月15日主力资金净买入1550.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675551177?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:03","pubTimestamp":1792112627,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，科伦药业报收于39.21元，上涨2.62%，换手率1.44%，成交量18.74万手，成交额7.34亿元。10月15日的资金流向数据方面，主力资金净流入1550.53万元，占总成交额2.11%，游资资金净流入2670.52万元，占总成交额3.64%，散户资金净流出4221.05万元，占总成交额5.75%。近5日资金流向一览见下表：科伦药业融资融券信息显示，融资方面，当日融资买入2274.57万元，融资偿还4712.92万元，融资净偿还2438.36万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","LU1979443071.USD","BK0239","LU1064131003.USD","LU2148510915.USD","LU1934453819.USD","BK0060","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675368910","title":"科伦药业（002422）披露2026年度中期分红派息实施公告，10月13日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675368910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675368910?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:33","pubTimestamp":1791902000,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，科伦药业报收于37.83元，较前一交易日下跌1.51%，最新总市值为601.79亿元。近日，四川科伦药业股份有限公司发布《2026年度中期分红派息实施公告》。公告显示，公司以现有总股本剔除已回购股份后的1,590,431,208股为基数，向全体股东每10股派发现金红利1.26元（含税）。股权登记日为2026年10月20日，除权除息日为2026年10月21日。现金分红总额为200,394,332.2080元。本次权益分派实施后，除权除息价格=股权登记日收盘价-0.1259722元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300040083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","BK0239","002422","LU1064130708.USD","BK0060","LU1934453819.USD","LU1064131003.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817578","title":"科伦药业（002422）10月8日主力资金净卖出7177.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674817578?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:16","pubTimestamp":1791508589,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，科伦药业报收于38.75元，下跌5.14%，换手率1.7%，成交量22.1万手，成交额8.7亿元。10月8日的资金流向数据方面，主力资金净流出7177.62万元，占总成交额8.25%，游资资金净流入2666.87万元，占总成交额3.06%，散户资金净流入4510.75万元，占总成交额5.18%。近5日资金流向一览见下表：科伦药业融资融券信息显示，融资方面，当日融资买入5360.39万元，融资偿还2592.2万元，融资净买入2768.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2148510915.USD","BK0239","002422","BK0060","LU1064131003.USD","LU1934453819.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673024001","title":"科伦药业：公司预计于2026年10月29日披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2673024001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673024001?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:12","pubTimestamp":1791447146,"startTime":"0","endTime":"0","summary":"证券之星消息，科伦药业(002422)10月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司什么时候披露三季度财务报表科伦药业回复：投资者您好，公司预计于2026年10月29日披露，谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800019172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","LU1064131003.USD","LU1064130708.USD","BK0239","002422","LU2148510915.USD","LU1934453819.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049013","title":"科伦药业（002422）9月30日主力资金净买入4730.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049013?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:04","pubTimestamp":1791421480,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，科伦药业报收于40.85元，上涨4.16%，换手率1.82%，成交量23.68万手，成交额9.64亿元。近5日资金流向一览见下表：科伦药业融资融券信息显示，融资方面，当日融资买入4197.16万元，融资偿还7129.93万元，融资净偿还2932.77万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1934453819.USD","BK0060","LU2148510915.USD","LU1979443071.USD","BK0239","LU1064131003.USD","LU1064130708.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669243159","title":"9月21日科伦药业涨6.81%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669243159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669243159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980296,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日科伦药业涨6.81%，收盘报42.48元，换手率2.86%，成交量37.15万手，成交额15.56亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共154家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为127.36亿元，最新净值1.9645，较上一交易日上涨0.67%，近一年下跌5.53%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","BK0060","LU2148510915.USD","BK0239","LU1064130708.USD","LU1979443071.USD","002422","LU1934453819.USD","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159298","title":"科伦药业涨6.81%，东海证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159298?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980287,"startTime":"0","endTime":"0","summary":"今日科伦药业涨6.81%，收盘报42.48元。2026年9月8日，东海证券研究员杜永宏发布了对科伦药业的研报《公司简评报告：收入端逐渐企稳，创新药快速放量》，该研报对科伦药业给出“买入”评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国盛证券的应沁心。科伦药业个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977592","title":"科伦博泰市值为何反超母公司？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977592","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668977592?lang=zh_cn&edition=full","pubTime":"2026-09-19 14:11","pubTimestamp":1789798262,"startTime":"0","endTime":"0","summary":"值得注意的是，科伦博泰的核心技术平台、生产产能、核心人才体系均依托母公司赋能搭建，母公司更是手握超半数股权，理论上完全享有创新资产的增值红利。商业化步入正轨，但盈利质量尚待验证科伦博泰2026年上半年的归母净利润为3.88亿元，扣除以权益结算的股份支付后的经调整净利润为4.79亿元，实现上市后首次转正。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789368221046307034","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","LU1064131003.USD","LU1064130708.USD","06990","002422","LU1979443071.USD","LU2148510915.USD","BK0239","LU1934453819.USD","BK0060","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643487","title":"9月15日科伦药业现1笔大宗交易 机构净卖出5747.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643487","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667643487?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:33","pubTimestamp":1789464798,"startTime":"0","endTime":"0","summary":"证券之星消息，9月15日科伦药业发生大宗交易，交易数据如下：大宗交易成交价格40.65元，成交141.39万股，成交金额5747.68万元，买方营业部为国泰海通证券股份有限公司深圳深南大道京基一百证券营业部，卖方营业部为机构专用。近三个月该股共发生9笔大宗交易，合计成交12.99万手，折价成交3笔。截至2026年9月15日收盘，科伦药业报收于40.65元，下跌1.76%，换手率0.85%，成交量10.98万手，成交额4.49亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500027834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064131003.USD","LU1064130708.USD","BK0060","002422","LU1979443071.USD","LU1934453819.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667065901","title":"9月14日科伦药业涨5.16%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667065901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667065901?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:39","pubTimestamp":1789375143,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日科伦药业涨5.16%，收盘报41.38元，换手率1.71%，成交量22.22万手，成交额9.04亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共154家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为127.36亿元，最新净值1.8588，较上一交易日下跌2.06%，近一年下跌9.56%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1979443071.USD","LU2148510915.USD","002422","BK0060","LU1934453819.USD","LU1064131003.USD","LU1064130708.USD","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659295","title":"科伦药业涨5.16%，东海证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659295?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:38","pubTimestamp":1789375133,"startTime":"0","endTime":"0","summary":"今日科伦药业涨5.16%，收盘报41.38元。2026年9月8日，东海证券研究员杜永宏发布了对科伦药业的研报《公司简评报告：收入端逐渐企稳，创新药快速放量》，该研报对科伦药业给出“买入”评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国盛证券的应沁心。科伦药业个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666831405","title":"瑞银：中国制药股上半年业绩好坏参半 首选先声药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2666831405","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666831405?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:58","pubTimestamp":1788940680,"startTime":"0","endTime":"0","summary":"瑞银发布研报称，中国制药股上半年业绩好坏参半，在九家评级的制药公司中，有五家业绩好过市场预期，分别为翰森制药(03692)、先声药业(02096)、中国生物制药(01177)、石药集团(01093)及科伦 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["000963","002422","BK0183","BK0196","BK0175","LU1979443071.USD","BK0239","LU1969619763.USD","BK0187","BK0188","LU1064131003.USD","BK0132","LU2148510915.USD","LU2328871848.SGD","LU1934453819.USD","BK0060","BK0209","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665228583","title":"东海证券：给予科伦药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2665228583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665228583?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:51","pubTimestamp":1788864708,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对科伦药业进行研究并发布了研究报告《公司简评报告：收入端逐渐企稳，创新药快速放量》，给予科伦药业买入评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，中性评级1家；过去90天内机构目标均价为45.93。本文数据来源于东海证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800029565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665331094","title":"科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2665331094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665331094?lang=zh_cn&edition=full","pubTime":"2026-09-08 02:15","pubTimestamp":1788804916,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业员工电子档案系统1.0》项目的软件著作权。今年以来科伦药业新注册软件著作权4个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了12.13亿元，同比增15.69%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8384次；财产线索方面有商标信息1209条，专利信息2081条，著作权信息19条；此外企业还拥有行政许可1370个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800000691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","159180","LU1064130708.USD","002422","LU2148510915.USD","BK0239","LU1064131003.USD","LU1934453819.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827136","title":"摩根士丹利将科伦药业评级上调至超配，目标价61元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664827136?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:17","pubTimestamp":1788423429,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2148510915.USD","BK0060","LU1934453819.USD","BK0239","LU1979443071.USD","LU1064130708.USD","LU1064131003.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793126188417,"stockEarnings":[{"period":"1week","weight":-0.0751},{"period":"1month","weight":0.0282},{"period":"3month","weight":-0.0717},{"period":"6month","weight":0.1721},{"period":"1year","weight":0.1674},{"period":"ytd","weight":0.3806}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.0471},{"period":"6month","weight":-0.1128},{"period":"1year","weight":-0.0872},{"period":"ytd","weight":-0.0808}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川科伦药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38356人(较上一季度减少6.56%)","perCapita":"33855股","listingDate":"2010-06-03","address":"四川省成都市新都区新都卫星城工业开发区南二路","registeredCapital":"159078万元","survey":"　　四川科伦药业股份有限公司的主营业务是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等27种剂型药品及中间体、原料药、医药包材等产品的研发、生产和销售。公司的主要产品是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液。公司位列“中国医药制造业百强”和“中国制造业500强”，荣登“中国化药企业百强”和“BigPharma企业创新力十强”等榜单。","listedPrice":83.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦药业,002422,科伦药业股票,科伦药业股票老虎,科伦药业股票老虎国际,科伦药业行情,科伦药业股票行情,科伦药业股价,科伦药业股市,科伦药业股票价格,科伦药业股票交易,科伦药业股票购买,科伦药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}